LQV Branded Vial
Cagrilintide
Includes syringes and alcohol pads with every vial shipment.
Cagrilintide
Cagrilintide is a long-acting amylin analog that enhances satiety signaling. It works through a distinct mechanism from GLP-1 therapies, targeting the amylin pathway to help patients feel full sooner and reduce overall food intake.
How It Works
Cagrilintide mimics the hormone amylin, which is co-secreted with insulin from pancreatic beta cells. By activating amylin receptors in the brain, it slows gastric emptying, promotes satiety, and suppresses post-meal glucagon secretion, leading to reduced caloric intake and improved blood sugar stability.
Key Benefits
Who It Is For
Adults looking for an alternative or complementary approach to GLP-1 receptor agonists for weight management. Suitable for patients who may benefit from amylin-based satiety enhancement. Medical screening and provider supervision are required.
Common Side Effects
Common side effects include nausea, injection site reactions, headache, and abdominal discomfort. Hypoglycemia may occur when used in combination with other glucose-lowering therapies. All potential risks are discussed during the initial medical evaluation.
Other GLP-1 Therapies
GLP-1 Therapy
Semaglutide
(SMA)
Semaglutide is a GLP-1 receptor agonist originally developed for type 2 diabetes management and now widely used for weight management. It helps reduce appetite, slow gastric emptying, and promote sustainable weight loss when combined with lifestyle modifications.
From $299
GLP-1 Therapy
Tirzepatide
Tirzepatide is a dual GIP/GLP-1 receptor agonist that targets two incretin pathways simultaneously. It has demonstrated significant efficacy in clinical weight loss trials and offers enhanced metabolic benefits compared to single-receptor therapies.
From $399
GLP-1 Therapy
Retatrutide
(RTA)
Retatrutide is a triple agonist targeting GLP-1, GIP, and glucagon receptors. By engaging three metabolic pathways, it represents the next generation of weight management therapies with the potential for greater efficacy in both weight loss and metabolic improvement.
From $449
Frequently Asked Questions
A therapy that mimics natural gut hormones involved in appetite and blood sugar regulation.
Yes. Medical evaluation and monitoring are required for all GLP-1 therapies.
Yes, following medical review and protocol setup.
Yes. Use the Speak To Our Medical Team tab to submit a form and request a consultation.
Prescription therapies require medical evaluation and supervision. Results vary. Side effects and risks are discussed during consultation.